| Authors: |
Screen M; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK michael.screen@babraham.ac.uk., Matheson LS; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK., Howden AJ; Cell Signalling and Immunology, University of Dundee, Dundee, UK., Strathdee D; Cancer Research UK Beatson Institute, Glasgow, UK., Willis AE; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Bushell M; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Sansom O; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Turner M; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK martin.turner@babraham.ac.uk. |
